The Institute for Prostate Cancer Research (IPCR) is a collaborative effort between Fred Hutch Cancer Center and UW Medicine. Together, we are a team of more than 40 scientists and scientist-clinicians in multiple disciplines.
Our expert team of scientists and clinicians work to fulfill our three-part mission:
To achieve this mission, we are committed to:
Private support is essential to fund research in laboratory, clinical and population settings, and ensures that the most talented researchers can focus their efforts on finding ways to prevent and cure prostate cancer.
Investing in the IPCR is a unique opportunity to build a lasting legacy in the battle against this devastating cancer.
Through cutting-edge research, scientists and clinicians provide hope for men with prostate cancer and their families in the Northwest and the world. We’ve already identified and/or assembled up to 80 percent of the genes expressed in prostate cancer, developed one of the largest serum and tissue banks in the world, undertaken some of the most advanced studies of bone biology and skeletal metastases, assembled information and genotypes for more than 300 families with hereditary prostate cancer and developed many new therapeutic strategies.
Our prostate cancer research targets the goals of developing better approaches for preventing, detecting and curing prostate cancer. We’ve categorized our projects and findings into five areas:
Exercise can help those living with prostate cancer to overcome the side effects of androgen-deprivation therapy, and it may have helpful effects on cancer biology. Yet many people with prostate cancer aren’t sure how to start an exercise routine. Fred Hutch experts and local patients created a series of videos to show people with prostate cancer how to safely exercise at home to improve their health.
The IPCR program is located at Fred Hutch's South Lake Union neighborhood of Seattle.
Mailing address:
Institute for Prostate Cancer Research
1100 Fairview Ave N
Seattle, WA 98109